JASON LEGER: Open Payments
NPI 1821095688 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$702 in 38 payments from 12 companies in 2025. Trend: 2023 $1,011 · 2024 $2,163 · 2025 $702
Food & beverage: $702
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $164 |
| Boston Scientific Corporation | 9 | $164 |
| SCPHARMACEUTICALS INC. | 5 | $92 |
| Inspire Medical Systems, Inc. | 1 | $55 |
| Abbott Laboratories | 2 | $45 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| ABIOMED | 2 | $34 |
| Merck Sharp & Dohme LLC | 2 | $32 |
| GENZYME CORPORATION | 1 | $31 |
| Amgen Inc. | 1 | $17 |
Products named: LEQVIO, FUROSCIX, INSPIRE, CARDIOMEMS, LUX-Dx Insertable Cardiac Monitor, VERQUVO, FABRAZYME, ELUVIA.
Industry payments across LA — which companies pay providers there.
